Relmada Therapeutics, Inc. trades by members of Congress

Purchases and sales of Relmada Therapeutics, Inc. shares that members of the House have disclosed since January 3, 2015, with the value range each one reported and a link to the original filing.

Purchases, last 12 months 0 trades None disclosed

Sales, last 12 months 0 trades None disclosed

Members trading, last 12 months 0 2 purchases and sales since January 3, 2015

Relmada Therapeutics, Inc. trades disclosed by members of Congress
				Report
Chris Jacobs House · R-NY 27	Sale (full)$1,001 - $15,000	Jan 20, 2023	Dec 12, 2022	Filing for RLMD on Dec 12, 2022
Chris Jacobs House · R-NY 27	Purchase$1,001 - $15,000	Dec 12, 2022	Nov 8, 2022	Filing for RLMD on Nov 8, 2022

Source: periodic transaction reports filed with the Clerk of the House of Representatives under the STOCK Act (Senate reports are not included yet). Members report trades by themselves, their spouses and dependent children. Amounts are the value ranges as filed, not exact figures, and a report can be filed up to 45 days after the trade, so the latest trades may not appear yet. Scanned paper reports are linked but not transcribed. By law (5 U.S.C. §13107) these reports may not be used for any commercial purpose other than by news and communications media for dissemination to the general public; we publish them free, as news.

← Back to Relmada Therapeutics, Inc. · Insider trading · Funds · All trades by members of Congress